To view the PDF file, sign up for a MySharenet subscription.

MEDICLINIC INTERNATIONAL PLC - Transactions by persons discharging managerial responsibilities and persons closely associated with them

Release Date: 12/07/2019 13:30
Code(s): MEI     PDF:  
Wrap Text
Transactions by persons discharging managerial responsibilities and persons closely associated with them

Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company" or the "Group")

12 July 2019


On 11 July 2019, Dr Ronnie Van der Merwe purchased 11 000 shares in Mediclinic International plc at
ZAR 56.90 per share. Accordingly, Dr Van der Merwe now owns a total of 51 630 Shares.

The following notification is made in accordance with Articles 19.1 and 19.3 of the Market Abuse

1.      Details of PDMR / persons closely associated with them ("PCA")
a)      Name                     Dr Carel Aron van der Merwe

2.      Reason for the notification
a)      Position / status        Chief Executive Officer - Mediclinic International plc
b)      Initial notification /   Initial Notification

3.      Details of the issuer, emission allowance market participant, auction platform, auctioneer or
        auction monitor
a)      Name                     Mediclinic International plc
b)      LEI                      2138002S5BSBIZTD5I60

4.      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each
        type of transaction; (iii) each date; and (iv) each place where transactions have been
a)      Description of the       Ordinary Shares
        financial instrument
        Identification Code      GB00B8HX8Z88
b)      Nature of the            Purchase of shares
c)      Price(s) and             Price(s)                           Volume(s)
        volume(s)                ZAR 56.84 per share                1 000
                                 ZAR 56.85 per share                2 831
                                 ZAR 56.86 per share                1 000
                                 ZAR 56.87 per share                3 000
                                 ZAR 56.98 per share                2 000
                                 ZAR 57.00 per share                1 169
d)      Aggregated
        Aggregated volume        11 000
        Price                    ZAR 56.90
e)      Date of the              11 July 2019
f)      Place of the             Johannesburg Stock Exchange

About Mediclinic International plc

Mediclinic is an international private healthcare services group, established in South Africa in 1983, with
divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates.

The Group's core purpose is to enhance the quality of life.

Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum
of care in such a way that the Group will be regarded as the most respected and trusted provider of
healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of
its markets.

Mediclinic comprises 77 hospitals, five sub-acute hospitals, 12 day case clinics and 21 outpatient clinics.
Hirslanden operates 18 hospitals, two day case clinics and three outpatient clinics in Switzerland with
more than 1 900 inpatient beds; Mediclinic Southern Africa operates 52 hospitals, five sub-acute
hospitals and 12 day case clinics with more than 8 500 inpatient beds; and Mediclinic Middle East
operates seven hospitals, two day case clinics and 21 outpatient clinics with more than 900 inpatient
beds in the United Arab Emirates.

The Company's primary listing is on the London Stock Exchange ("LSE") in the United Kingdom, with
secondary listings on the JSE Ltd in South Africa and the Namibian Stock Exchange in Namibia.

Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group
based in the United Kingdom and listed on the LSE.

For further information, please contact:

Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569

Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
+44 (0)20 3786 8181

Media queries
FTI Consulting
Brett Pollard/Debbie Scott - UK
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank
JSE Ltd sponsor: Rand Merchant Bank (A division of FirstRand Bank Ltd)
NSX sponsor: Simonis Storm Securities (Pty) Ltd

Date: 12/07/2019 01:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story